FTSE 100 news / Companies and sectors / Smith & Nephew / 6 October 2026

Smith & Nephew (SN): news on Tuesday 6 October 2026

+4.0 positive

Coverage centred on product news, with regulatory clearance for the LANDMARK knee system and the launch of the EVOS system. Broker support was only lukewarm with a Hold rating, and the notes removal from the NYSE listing looked procedural.

What drove it

LANDMARK knee clearance
EVOS system launch
2027 notes NYSE removal

The 5 stories

Each headline's own score, strongest first. Links go to the publisher.

+8.7 Does FTSE 100 Medtech (LSE:SNN) Gain A Fresh Orthopaedics Catalyst From Its LANDMARK Knee System Clearance? Kalkine Media
LANDMARK knee system clearance is a fresh orthopaedics catalyst.
+3.5 Smith & Nephew launches EVOS system and Berenberg keeps Hold on Smith & Nephew stock AD HOC NEWS
New EVOS system launch, tempered by Berenberg's neutral Hold rating.
+0.8 Smith & Nephew stock sees USD 350 million debt reset AD HOC NEWS
Debt notes removal/refinancing reported; largely routine balance sheet housekeeping.
0.0 5.150% notes due 2027 are named in Smith & Nephew (NYSE: SNN)'s NYSE removal notice. Stock Titan
Notice of notes removal from NYSE; factual and routine.
0.0 Smith & Nephew PLC Removes 5.150% Notes Due 2027 from NYSE Listing Kalkine Media
NYSE delisting of 2027 notes; procedural, no clear prospects impact.

Smith & Nephew: every day · Pharma and healthcare on 6 October 2026 · FTSE 100 overview for the day